We’ve been playing our part in the annual ritual of blogging about voting policy updates from bigassetmanagers. They made very few updates to executive compensation policies – and that trend also held true with voting policies that were published in March. Here are a few (incremental) changes that may apply to your company:
– Fidelity – consistent with policy clarifications that Fidelity isn’t intending to influence control of any portfolio company, Fidelity’s policy that it will vote against compensation committee members if the company hasn’t addressed say-on-pay concerns now refers to “concerns raised by shareholders” instead of “concerns communicated by Fidelity”
– T. Rowe Price – clarifying that T. Rowe has flexibility in deciding to vote against compensation committee members in the event of poor compensation practices or option repricings
Check out our “Investor Voting Policies” Practice Area for voting guidelines of other investors and asset managers. We’re blogging on TheCorporporateCounsel.net about changes to policies that are unrelated to executive compensation.
ESG metrics have been under the microscope for some time now, with investors concerned about “ESG overperformance” and companies setting “softball” goals, causing outsized payouts compared to company financial performance. Now, as Liz shared last week, the use of ESG measures seems to be reversing course with a renewed focus on financial measures.
For anyone still tinkering with proxy disclosures describing the continued use of ESG measures in 2024 plans, WTW recently sought to better understand what investors are looking for when they consider pay proposals at companies that use ESG metrics. While many investors reported that they consider the use of ESG metrics on a case-by-case basis, WTW shared some common pitfalls that were identified by surveyed investors.
– Lack of clear connection to business strategy and value creation. This includes the use of metrics that overly rely on subjective judgment, or the use of ESG metrics that are not clearly defined or do not clearly align with the company’s strategy, competitive strengths or material business risks.
– Use of broad ESG indices or compliance-related metrics. Investors do not favor ESG indices as an incentive metric because they are too broad and lack focus. The use of ESG indices also goes against the overarching theme of business materiality. In addition, investors cautioned against the use of compliance-related metrics, as they consider compliance a baseline expectation of executive performance.
– Too many metrics. Too many metrics over-complicate incentive plans and dilute the impact of individual metrics. This weakens the alignment between pay and performance and makes it less meaningful for incentive plan participants. For similar reasons, investors also cautioned the use of less measurable ESG scorecards with undefined weighting of each scorecard element. Additionally, the optics is that the company is building in flexibility to selectively choose which metrics they would add weight to retrospectively when assessing performance and deciding associated pay outcomes.
– Non-financial metrics weighted more heavily than financial metrics. Investors generally shy away from a prescriptive guideline on a minimum or maximum weighting on ESG metrics. However, they noted that, in principle, a small weighting (e.g., lower than 10%) likely will not impact behaviors. A thoughtful approach to selection will naturally result in more meaningful weighting on each individual metric. There also was consensus among the investors that if ESG or non-financial metrics are weighted more heavily than financial or shareholder return metrics, it will draw closer examination. Some investors also expressed concern about high ESG scores offsetting lackluster financial performance in remuneration outcomes.
– Consistent above-target payout. This may signal a lack of rigor on performance goal setting, especially for qualitative measures that require judgment-based assessment.
– Lack of transparent disclosure. Like disclosures on financial metrics, investors expect transparency in the rationale behind metric selection (both retrospective and prospective), with acknowledgement that market norms vary by region), weighting for each metric and achievement against targets. While some companies may cite commercial sensitivity as an argument to omit disclosure of performance goals, investors are mostly unsympathetic to this argument. They assert that ESG targets are generally far less sensitive than financial targets and, if commercial sensitivity does come into play, companies should still be able to disclose the targets and achievement levels retrospectively, after the performance period concludes. Prospective disclosure of targets is encouraged and should clearly show how short- and long-term incentive targets (which often have a one- to three-year time horizon) connect to longer-term sustainability commitments, such as net-zero goals and their transition pathways.
In terms of institutional investor policies on this topic, unsurprisingly, many are still not looking for companies to incorporate ESG measures, but when they’re used, they want to see alignment, goal rigor and transparency.
If late 2024 PvP comment letters are any indication, there seems to be confusion about what companies need to say about non-GAAP Company-Selected Measures (and additional PvP measures a company may elect to provide). Under Item 402(v)(2)(vi) of Regulation S-K, non-GAAP Company-Selected Measures will not be subject to Regulation G or Item 10(e) of Regulation S-K but companies must disclose how the number is calculated from the audited financial statements. (This requirement intentionally tracked the requirements related to disclosing target levels that are non-GAAP financial measures in CD&A under Instruction 5 to Item 402(b).)
The confusion might stem from the fact that Instruction 5 is limited to target compensation levels. Regulation S-K CDI 118.08 says the instruction does not extend to non-GAAP financial information that does not relate to the disclosure of target levels, so when non-GAAP measures are disclosed in the proxy for other purposes, those aresubject to Reg. G and Item 10(e) requirements. But, per the CDI, the Staff will not object if the company provides the disclosure by prominent cross-reference to a proxy statement annex or pages in the Form 10-K. Many companies do this.
It appears that several companies attempted to comply with the requirement to disclose how their non-GAAP Company-Selected Measure in 2024 proxies is calculated from the audited financial statements by cross-referencing other disclosures — either internally in the proxy or to the Form 10-K. But incorporation by reference to a separate filing (even the 10-K) doesn’t work. Cross-referencing disclosure in another section of the proxy statement — like the disclosure intended to comply with Instruction 5 to Item 402(b) — would comply if that section included the full required explanation of how the Company-Selected Measure is calculated from the audited financial statements.
While that explanation will necessarily be tailored to the company and the measure, here’s an explanation provided to the Staff in a response letter from AdaptHealth Corp. of how a Company-Selected Measure — here, Adjusted EBITDA — is calculated from the audited financial statements:
In the 2024 Proxy Statement, the Company calculated Adjusted EBITDA for each year disclosed on the Pay Versus Performance Table as EBITDA, plus loss on extinguishment of debt, equity-based compensation expense, transaction costs, change in fair value of the warrant liability, goodwill impairment, change in fair value of the contingent consideration common shares liability, litigation settlement expense, and certain other nonrecurring items of expense or income. The Company calculated EBITDA as part of the calculation of Adjusted EBITDA for each year disclosed on the Pay Versus Performance Table as net income (loss) attributable to [the company], plus net income (loss) attributable to noncontrolling interests, interest expense, net, income tax expense (benefit), and depreciation and amortization, including patient equipment depreciation.
One of the things I find tricky about the prescriptive rules governing the disclosure of executive compensation arrangements is their reference to and dependence on how stock and option awards are accounted for and reflected in the financial statements. The Summary Compensation Table Chapter of the Executive Compensation Disclosure Treatise has 170 references to ASC 718! So, when I saw that this BDO publication on ASC 718 had a section called “Accounting for Share-Based Payments In a Nutshell,” I picked it up to peruse!
Here’s its brief explanation of a difficult topic — modifying an existing award’s terms and conditions — from the “In a Nutshell” section:
– An entity may change the terms or conditions of an existing share-based payment award. An entity must account for a modification if it affects the award’s classification, vesting, or fair value.
– A modification to an equity-classified award is treated as an exchange of the original award for a new award with equal or greater value. If a grantee receives incremental value as a result of the modification, additional compensation cost is recognized on the modification date (for vested awards) or over the remaining vesting period (for unvested awards).
– A modification to a liability-classified award is remeasured based on the fair value of the award using the modified terms at the modification date and each reporting period thereafter, irrespective of whether the modification resulted in incremental value to the grantee.
Modifications that change an award’s vesting conditions affect the amount of compensation cost to be recognized based on whether the award is probable of vesting under its new terms. The accounting for a modification that results in reclassifying an award depends on the award’s classification before and after the modification.
At 258 pages long, the blueprint goes into much greater detail on this and other ASC 718-related topics.
Compensation Advisory Partners (CAP) recently reported on its review of CEO pay levels among 50 companies with fiscal years ending between August and October 2024. Here are some key findings from the report:
2024 median financial performance – as measured by revenue, earnings before interest and taxes (EBIT), and earnings per share (EPS) – was generally flat and consistent with 2023 performance.
Median CEO total direct compensation increased +9% year over year, driven by a +14% increase in actual bonus payout and a +7% increase in the grant-date value of long-term incentives (LTI).
For the second year in a row, median bonus payouts for CEOs were around target (i.e., 104% of target). Although financial performance was generally flat and annual incentive achievement was around target, CEO bonus payouts were up significantly. This is because, in general, companies with significant increases in bonus payouts (on average, approximately +280% increase) either rebounded from low payouts in 2023 or had continued sustained performance in 2024 and these increases were larger than the percentage change for companies that saw a decline in bonus (approximately 45%, on average).
It also found that approximately 25% of these companies adjusted an executive’s payout through individual performance or discretionary adjustments.
Less than half of the Early Filers use individual performance as a component of the annual incentive payout. Companies use individual performance to align the incentive payout with an executive’s contribution to the company and the results can raise or lower an executive’s payout relative to corporate performance.
Companies can also make discretionary adjustments to recognize overall company performance (more broadly than incentive plan metrics). Similar to individual performance, these adjustments may raise or lower the bonus payout. Only a handful of Early Filers made discretionary adjustments in 2024.
For 2025, CAP anticipates modest increases to CEO LTI given strong 2024 TSR performance, but they include cautionary notes. First, they say macroeconomic uncertainty is already impacting TSR (slightly down since September 30), and the unknown impact of tariffs means that some companies may have — and some companies may have not — incorporated tariff impacts in setting compensation metrics targets. My takeaway is that 2025 is going to be (already is) a very complicated and challenging year for incentivizing and retaining executives, disclosing decisions and garnering investor support for pay programs.
A few weeks ago, I recommended a few action items that can help you be prepared to implement your clawback policy in the unfortunate event your company determines that it needs to restate financials. Meredith has blogged about “the unlucky first few” companies that have had to analyze recoupment and make the required Item 402(w) disclosures. But now, a higher profile example has arrived, which will no doubt be a reference point for other companies that find themselves in this position.
You probably remember the news late last year about a “rogue employee” at a prominent retailer hiding over $150 million in cumulative delivery expenses over the course of nearly three years. At the time, the company disclosed that revisions should be made to its historical consolidated financial statements. The impact was not material to any prior period, but a correction was made in the Form 10-Q for the third fiscal quarter – which ended November 2, 2024.
This apparently constituted a “little r” restatement. Both “clawback”-related checkboxes were marked on the Form 10-K that the company filed a couple of weeks ago. Now, the proxy statement is also here, with the “recoupment” disclosure beginning in detail on page 88. Here’s an excerpt:
The financial performance metrics used to determine payouts under the 2023 annual incentive plan (“STI Plan”) were total revenue (40%) and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) (40%). Total revenue was not affected by the error correction. The performance metrics used to determine payouts under the 2021 – 2023 performance share plan (“PRSU Plan”) were digital sales (50%) and relative total shareholder return (rTSR) (50%) determined over a three-year performance period using the S&P Retail Select Industry Index as the peer group. Digital sales were not affected by the error correction.
The proxy goes on to describe the recoupment analysis for the relevant metrics. Because of the rTSR metric, the company engaged a third party to conduct an event study and estimate the effect of the accounting restatement on the incentive metrics for the PRSU element of compensation. The committee determined there was no erroneously awarded compensation for the PRSUs, but the STI payouts were a different story:
The erroneously awarded compensation pursuant to the 2023 STI Plan was paid to Covered Officers in cash, net of tax withholding, in April 2024. The aggregate amount of erroneously awarded compensation that remained outstanding at the end of fiscal 2024 was $609,613, and at April 1, 2025 was $352,093. The CMD Committee will seek to recover the remaining amount of the erroneously awarded compensation from Covered Officers in accordance with the Clawback Policy during fiscal 2025.
This disclosure illustrates that the clawback process may be well underway – and perhaps even complete – by the time it’s disclosed in the proxy statement. The company appears to have acted quickly here.
Although this is one of the first companies that has had to analyze and disclose a Dodd-Frank clawback, it won’t be the last. Now there’s an instructive real-world framework.
Back in December, ISS published an “executive compensation” FAQ to alert companies that it would be taking a closer look at performance-vesting equity disclosures in the upcoming proxy season, especially for companies that show a disconnect between pay and performance. For example, ISS wants to see disclosure of forward-looking goals and robust disclosure of closing-cycle vesting results.
Now, the proxy advisor has published a “proxy season preview” – which includes a reminder about this FAQ. The report also contains other governance and executive compensation predictions & recommendations. Here are a few compensation-related takeaways:
– Fewer boards are tasked with demonstrating robust say-on-pay responsiveness. Last year’s higher say-on-pay support levels overall means that fewer boards are tasked with demonstrating robust responsiveness to low vote results. Core pay-for-performance areas are expected to remain in focus, such as the proportion of performance-conditioned pay, goal rigor, clarity of disclosure, and one-time awards.
– Performance equity disclosure and design deficiencies will be subject to greater scrutiny going forward. Beginning with the 2025 proxy season, ISS will place a greater focus on performance-vesting equity disclosure and design aspects, particularly for companies that exhibit a quantitative pay-for-performance misalignment. Multiple concerns identified with respect to performance equity programs will be more likely to result in an adverse vote recommendation in the context of a quantitative pay-for-performance misalignment.
– Investors may see increases in security-related perquisites in 2025. As many companies reevaluate the need for new or enhanced security protections for their top executives in the wake of recent events, security-related perquisites are likely to come to the forefront for many companies. It remains to be seen what impact this will have for 2025 proxy disclosures or how investors will evaluate potential increases in such perquisites, which often include executives’ personal use of company aircraft.
– Investors should be on the lookout for new clawback disclosures. Most listed companies have now implemented clawback policies that comply with the final Dodd-Frank rule and corresponding listing standards. Many investors will be on the lookout for additional disclosures for companies conducting clawback analyses, particularly given that the 2025 proxy season marks the first year in which end-of-year pay decisions are expressly subject to potential clawback under the listing standards.
As Dave Lynn noted in this site’s January webcast on “Your Upcoming Proxy Disclosures,” ISS added the “performance-vesting equity” FAQ in connection with potentially softening its stance on the heavy use of time-vested equity in future policy updates. For more about this year’s proxy advisor policies, check out this 16-minute podcast that Meredith taped with Compensation Advisory Partners’ Shaun Bisman.
Pearl Meyer recently reviewed the first 100 proxies filed by S&P 500 companies in 2025. These proxies primarily report on 2024 compensation, although some companies also disclose what they plan to do in 2025. Here are the key takeaways:
– Median CEO total compensation was $17.7 million in 2024, reflecting a 9.8% rise over 2023, mostly driven by increases in short- and long-term incentive values.
– Performance-based stock awards continue to be the predominant long-term incentive vehicle. Relative Total Shareholder Return (rTSR) continues to be the most prevalent performance-based equity award measure, with 64% of the first 100 S&P 500 proxy filers using that measure in 2024.
– Security-related perquisites increased in prevalence, likely reflecting heightened board concerns over executive safety.
– Diversity-related incentive measures significantly decreased in prevalence as companies increased focus on financial and strategic measures of performance.
On security-related perks, the memo gives this additional color:
Among the first 100 S&P 500 proxy filers in 2025, there is early evidence of an increase in executive security-related perquisites. We found the prevalence of disclosed security perquisites for CEOs increased from 24% in 2023 to 31% in 2024.
Following the United Healthcare murder late in 2024, boards are increasingly concerned as to the safety of CEOs and senior leadership. We expect the prevalence to increase further in 2025 as several companies prospectively disclosed adoptions of security programs in 2025 that don’t yet show up as perquisites for 2024.
On diversity-related metrics, I blogged in February about how companies have been refining or removing these metrics over the course of the past 1-2 years. Here’s what Pearl Meyer found on that from the early 2025 proxy statements:
The significant increase in recent years in the use of ESG and, more specifically, diversity and inclusion measures in executive incentives appears to be reversing course, at least in part due to the current political and social environment. Among the first 100 S&P 500 proxy filers, the prevalence of diversity measures in incentive programs sharply declined from 65% in 2023 to 35% in 2024. We expect a further decline in prevalence in 2025 as several companies proactively disclosed discontinuation for 2025.